NCT00054119View on ClinicalTrials.gov

Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2005

Conditions
Primary Peritoneal CarcinomaRecurrent Ovarian Carcinoma
Interventions
DRUG

Cositecan

Given IV

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

85012

Gynecologic Oncology Group of Arizona, Phoenix

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00054119 - Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter